ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

ACR Convergence 2020

November 5-9, 2020. All Virtual.

View by Number View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f g h i j k l m n o [p] q r s t u v w x y z
  • Abstract Number: 1603
    P4 Index Correlates with RAPID3 and Disease-Specific Indices in Rheumatoid Arthritis (RA) and Axial Spondyloarthritis (axSpA)
  • Abstract Number: 0735
    Paediatric Sarcoidosis: Phenotype of a Retrospective Cohort of Biopsy-proven Patients
  • Abstract Number: 1237
    Pain and Other Patient-Reported Outcomes in Patients with Rheumatoid Arthritis Who Did or Did Not Achieve Treatment Response Based on Improvement in Swollen Joints in Tocilizumab Clinical Trials
  • Abstract Number: 1085
    Pain in Myositis Is Associated with the Disease Activity
  • Abstract Number: 0028
    Pain in the Time of Corona: Impact of COVID 19 Outbreak on Fibromyalgia Patients
  • Abstract Number: 1109
    Pain in Women with Knee and/or Hip Osteoarthritis Is Related to Systemic Inflammation and to Adipose Tissue Dysfunction and Distribution: A Cross-sectional Metabolic Biomarkers Cohort Study
  • Abstract Number: 1030
    Pain Medication Use Among Ankylosing Spondylitis and Psoriatic Arthritis Patients Before and After Initiation of Biologic Therapy
  • Abstract Number: 1490
    Pain Rating Variability and Response to Treatment in Osteoarthritis Clinical Trials
  • Abstract Number: 1655
    Pain Reduction Post Total Knee Replacement in Opioid Users and Non-users
  • Abstract Number: 0275
    Paradoxical Relationship Between Disease Activity and Satisfaction with Care in Lupus
  • Abstract Number: 1979
    Participant Engagement and Adherence in an ArthritisPower Real-World Study to Capture Smartwatch and Patient-Reported Outcome Data Among Rheumatoid Arthritis Patients
  • Abstract Number: 1000
    Passive Smoking Throughout the Life Course and the Risk of Incident Rheumatoid Arthritis in Adulthood Among Women
  • Abstract Number: 0835
    Pathogenic Effect of Chronic Stress-induced interleukin-12/23p40 on Neuropsychiatric System in Lupus-prone Mouse
  • Abstract Number: 0991
    Pathogenic, Glycolytic PD-1+ B Cells Accumulate in the Hypoxic RA Joint
  • Abstract Number: 1394
    Pathway to Systemic Sclerosis: Concerning Patients’ Experiences During the Diagnostic Process
  • Abstract Number: 0608
    Patient and Parent Perspectives in a Academic Pediatric Rheumatology Transition Clinic
  • Abstract Number: 0593
    Patient Characteristics and Factors Affecting Decision-Making Regarding Total Knee Replacement by Different Types of Physicians Treating Patients with Knee OA
  • Abstract Number: 0678
    Patient Characteristics and Patterns of Urate-lowering Treatments in Older Patients with Incident Gout
  • Abstract Number: PP08
    Patient Participation in the COVID-19 Global Rheumatology Alliance as a Model for Involving Patients from the Ground Up
  • Abstract Number: 1133
    Patient Perceptions of Diagnosis, Tests, Treatments, Adherence and the Impact on Their Disease Understanding and Participation in Research Studies
  • Abstract Number: 1316
    Patient Perceptions of Fibromyalgia Symptoms and the Overlap with Axial Spondyloarthritis
  • Abstract Number: 1131
    Patient Perspective of Helpfulness of Lupus Medications: A Qualitative Study of Medication Use Within the Type 1 and 2 SLE Model
  • Abstract Number: 0256
    Patient Perspective of the Type 1 and 2 SLE Model: A Qualitative Study
  • Abstract Number: 1130
    Patient Perspectives on Biobanking and Data-linkage for Rheumatic Disease Research
  • Abstract Number: 1125
    Patient Reported Impact of Lupus on Quality of Life
  • Abstract Number: 1494
    Patient-Reported Adverse Events, Quality of Life and Treatment Adherence in Juvenile Idiopathic Arthritis: Analysis of Two Large International Cohorts
  • Abstract Number: 1769
    Patient-reported COVID-19 Infection in Pregnant Women with Rheumatic Disease: Data from the COVID-19 Global Rheumatology Alliance Patient Experience Survey
  • Abstract Number: 0159
    Patient-Reported Data Show the Impact of Time to Diagnosis in RA
  • Abstract Number: 1866
    Patient-reported Impact of Axial Spondyloarthritis on Working Life. Results from the Spanish Atlas 2017
  • Abstract Number: 0169
    Patient-Reported Outcomes Differentiate Between Remission and Low Disease Activity in Psoriatic Arthritis
  • Abstract Number: 0526
    Patient-Reported Outcomes in Antiphospholipid Syndrome
  • Abstract Number: 1081
    Patient-reported Outcomes in Early Autoimmune Inflammatory Myopathies
  • Abstract Number: 1241
    Patient-Reported Outcomes in Rheumatoid Arthritis Patients Treated with Tofacitinib or Biological DMARDs in Real Life Conditions in Two Latin America Countries
  • Abstract Number: 1210
    Patient-Reported Outcomes Measurement Information System (PROMIS) Assessment of Response to Treatment with Golimumab IV or Infliximab in Rheumatoid Arthritis Patients: Results from a Phase 4 Study
  • Abstract Number: 1728
    Patient-Reported Outcomes of Upadacitinib versus Abatacept in Patients with Rheumatoid Arthritis and an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drugs: 12-Week Results of a Phase 3 Study
  • Abstract Number: 0011
    Patients Receiving Cytokine Inhibitors Have Low Prevalence of SARS-CoV-2 Infection
  • Abstract Number: 1248
    Patients Seropositive for La/SSB Without Ro/SSA Differ from Those Displaying La/SSB with Ro/SSA in a Single Center Sjogren’s Cohort
  • Abstract Number: 0193
    Patients with Asthma Have a Higher Risk of Rheumatoid Arthritis: A Systematic Review and Meta-analysis
  • Abstract Number: 1739
    Patients with Early Rheumatoid Arthritis Considered to Have a Favourable Risk Profile and Treated According to a Step-up Strategy Have an Increased Risk of Chronic Analgesic Consumption
  • Abstract Number: 1981
    Patients with Inflammatory Arthritis Who Are More Adherent to Treatment Do Not Perform More Physical Activity Collected by Smartphone Apps: A Cross-sectional Study of 101 Patients, the ImBAIA Study
  • Abstract Number: 0362
    Patients with Psoriatic Arthritis Treated with Guselkumab Achieved Psoriasis-Related Symptom-Free State and Had No Skin Condition Impact on Their Health Related Quality of Life
  • Abstract Number: PP10
    Patients with Relapsing Polychondritis (“RP”) and an Advocate Manufactured Custom Cloth Masks to Combat COVID-19: This Mask Project Provided a Sense of Purpose, Created Unity, Increased Awareness of RP, Facilitated Research, and Generated Hope
  • Abstract Number: 1733
    Patients with Rheumatoid Arthritis and Comorbid Depression Have High Levels of RAPID3 (Routine Assessment of Patient Index Data) and FAST3 (Fibromyalgia Assessment Screening Index) on a Multidimensional Health Assessment Questionnaire (MDHAQ)
  • Abstract Number: 1742
    Patients’ and Rheumatologists’ Perceptions on Preventive Intervention in Rheumatoid Arthritis and Axial Spondyloarthritis
  • Abstract Number: 0146
    Patients’ Perceptions and Expectations Towards the Role of Rheumatologists in the Recommendations of Physical Activity’s Practice – A Cross-sectional Study Involving 308 Patients Living with Rheumatoid Arthritis in France
  • Abstract Number: 1892
    Pattern and Influential Factors in Promoting Treat-to-Target (T2T) for F Ankylosing Spondylitis (AS) Patients with the App of Smart System of Disease Management (SSDM): A Cohort Study from China
  • Abstract Number: 1958
    Patterns and Impact of Long-term Glucocorticoid Use on RA Patients at Risk for Major Adverse Cardiac Events
  • Abstract Number: 1727
    Patterns of Fatigue in Early RA over 10 Years: Results from the ESPOIR Cohort
  • Abstract Number: 1674
    Pediatric and Adolescent One Year Protocol Kidney Biopsies Should Be Performed, Even in Patients with Complete Remission of Their Lupus Nephritis
  • Abstract Number: 0530
    Pediatric APS: Clinical Features, Therapeutic Interventions, and Damage in a Series of 22 Cases
  • Abstract Number: 0791
    Peficitinib Inhibits Angiogenesis via Suppression of VEGF Production in Rheumatoid Arthritis Fibroblast-like Synoviocytes
  • Abstract Number: 1267
    Perceived Stress During the COVID-19 Pandemic Independently Associates with Worse Patient-Reported Outcomes in Systemic Lupus Erythematosus (SLE)
  • Abstract Number: 0586
    Performance Characteristics of ANA by Elisa and Immunofluorescence
  • Abstract Number: 1885
    Performance of SASDAS (Simplified Axial Spondyloarthritis Disease Activity Score) versus ASDAS in a Post Hoc Analysis of a Randomized Controlled Clinical Trial
  • Abstract Number: 1185
    Performance of the MBDA-based CVD Risk Score in RA Patient Groups of Clinical Interest
  • Abstract Number: 1303
    Performance of Three Referral Algorithms for Diagnosing Axial Spondyloarthritis: Results from the Screening in Axial Spondyloarthritis for Psoriasis, Iritis, and Colitis Cohort
  • Abstract Number: 1743
    Perioperative Steroids in Rheumatoid Arthritis Patients Having Total Joint Replacements: Help or Harm?
  • Abstract Number: 0794
    Peripheral Blood T and B Lymphocyte Subsets in Arthritis in the Elderly
  • Abstract Number: 1239
    Peripheral Protein Biomarker Changes Following Selective Inhibition of Janus Kinase 1 (JAK1) by Filgotinib in Methotrexate Naïve Adults with Moderately-to-Severely Active Rheumatoid Arthritis
  • Abstract Number: 1286
    Personalizing Cardiovascular Risk Prediction for Patients with Systemic Lupus Erythematosus by Physician Global Assessment of Disease Activity
  • Abstract Number: 1161
    Perspectives of Radiologist Physicians in the Imaging of Chronic Nonbacterial Osteomyelitis
  • Abstract Number: 0148
    Perspectives on Treatment Burden for Methotrexate and TNF-inhibitors Among Psoriatic Arthritis and Rheumatoid Arthritis Patients: A Qualitative Study
  • Abstract Number: 0619
    Pharmacist Intervention: Reducing Insurance Denials of Specialty Medications
  • Abstract Number: 0133
    Pharmacist-Driven Clinic Development for Patients with Incidental Vertebral or Hip Fractures
  • Abstract Number: 0438
    Pharmacist-Led Multidisciplinary Approach to Opioid Tapering in a Large Private Rheumatology Practice
  • Abstract Number: 1041
    Pharmaco-epidemiology of Non-infectious Ocular Inflammatory Disease in a Tertiary Academic Center
  • Abstract Number: 0204
    Pharmacokinetics and Safety of CT-P17, a Proposed High Concentration (100 mg/mL) Adalimumab Biosimilar, in Comparison with EU-Approved Adalimumab and US-Licensed Adalimumab; Results of a Phase 1, Randomized, Double-blind, Three-arm, Single-dose Study in Healthy Subjects
  • Abstract Number: 0683
    Pharmacokinetics of Pegloticase and Methotrexate Polyglutamate(s) in Patients with Uncontrolled Gout Receiving Pegloticase and Co-treatment of Methotrexate
  • Abstract Number: 0386
    Phase 1 Clinical Study of MGTA-145 in Combination with Plerixafor Shows Rapid Single-Day Mobilization and Collection of CD34+ Hematopoietic Stem Cells Without G-CSF
  • Abstract Number: 1627
    Phase I Trial of High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients with Mild COVID-19: A Study in the Effects of Shifting Public Opinion on Patient Enrollment
  • Abstract Number: 0781
    Phenotypic and Functional Characterisation of Synovial Fluid-derived Fibroblast-like Synoviocytes in Rheumatoid Arthritis
  • Abstract Number: 0551
    Physical Performance as a Mediator of the Association Between Depression and Pain in Knee Osteoarthritis
  • Abstract Number: 1385
    Physical Therapy in Patients with Systemic Sclerosis: The Perspective of Physical Therapists on Current Delivery and Educational Needs
  • Abstract Number: 1146
    Pilot Study of an Internet-Based Pain Coping Skills Training Program for Patients with Systemic Lupus Erythematosus
  • Abstract Number: 1601
    Pilot Testing Supports Utility of a Point-of-Care Dashboard to Enhance Patient and Clinician Partnerships in the Management of RA
  • Abstract Number: 1645
    Placebo Group Responses in Clinical Trials of Patients with Osteoarthritis: Data from the Tanezumab Development Program
  • Abstract Number: 1087
    Plasma-derived Extracellular Vesicles Induced STING-mediated Proinflammatory Effects in Dermatomyositis
  • Abstract Number: 0763
    Plasmatic Proteome in Individuals with Arthralgia at Risk of Developing Rheumatoid Arthritis
  • Abstract Number: 1792
    Platelet-bound C4d Is Associated with an Increased Risk of Arterial and Venous Thromboses in SLE
  • Abstract Number: 1510
    Platelet-bound C4d Is Associated with Platelet Activation and Arterial Thrombotic Events
  • Abstract Number: 1625
    Pneumocystis Jiroveci Pneumonia in Immunocompromised Patients with Rheumatologic Disease in a Single, Tertiary Medical Center
  • Abstract Number: 1698
    Polyarthritis Workup in Primary Care Setting : How Are We Doing?
  • Abstract Number: 0421
    Polymyalgia Rheumatica Is Associated with Later Menopause: An Observational Study
  • Abstract Number: 0659
    Polynesian-Specific Gout-Associated Frameshift Variant in PRPSAP1
  • Abstract Number: 0349
    Pooled Safety Results from Two Phase-3 Trials of Guselkumab in Patients with Psoriatic Arthritis Through 1 Year
  • Abstract Number: 1395
    Poor Maternal and Fetal Outcome in Indian Women with Systemic Sclerosis: Interview-based Study at a Tertiary Center in India
  • Abstract Number: 1692
    Poor Physical Activity Levels and Cardiorespiratory Fitness Among Patients with Childhood-Onset Takayasu Arteritis in Remission
  • Abstract Number: 1951
    Possible Involvement of Fractalkine/CX3CR1 Axis in Peripheral CD14++CD16+ Monocytes in Disease Development of Patients with Systemic Lupus Erythematosus
  • Abstract Number: 1006
    Post-menopausal Rheumatoid Arthritis Is Inversely Associated with Lifetime High Level of Estrogen Exposure in the French E3N Cohort
  • Abstract Number: 1271
    Post-Traumatic Stress Disorder (PTSD) and Risk of Systemic Lupus Erythematosus (SLE) Among Medicaid Recipients
  • Abstract Number: 0733
    Practice Patterns for Tapering Medications in the Treatment of JIA-associated Uveitis
  • Abstract Number: 0692
    Pre-Operative Opioid Usage Increases Length of Stay for Rheumatoid Arthritis Patients Undergoing Total Hip Arthroplasty and Total Knee Arthroplasty
  • Abstract Number: 0033
    Pre-pregnancy Long Non-coding RNA Expression Signatures Among Women with Rheumatoid Arthritis Who Improve or Worsen During Pregnancy
  • Abstract Number: 1975
    Predicting Bone Mineral Density of Lumbar Vertebrae by Assessing Plain Film with Deep Learning
  • Abstract Number: 1346
    Predicting Major Treatment Response to Tumor Necrosis Factor Inhibitorsin Patients with Ankylosing Spondylitis
  • Abstract Number: 1722
    Predicting Rheumatoid Arthritis Using the Symptoms in Persons at Risk of Rheumatoid Arthritis (SPARRA) Questionnaire
  • Abstract Number: 1117
    Prediction Model for Progression to Different Find-Grained MRI-Based Osteoarthritis Severity States: The Vancouver Longitudinal Study of Early Knee Osteoarthritis (VALSEKO)
  • Abstract Number: 1294
    Prediction of Damage in SLE Using Unbiased Analysis of Large Datasets
  • Abstract Number: 1752
    Prediction of Responder and Non-responder to JAK Inhibitors in Patients with Rheumatoid Arthritis: A Pilot Study with Integrative Cluster Analysis
  • Abstract Number: 1987
    Predictors of Adverse Outcomes in Patients with Childhood-Onset Systemic Lupus Erythematosus Transitioning to Adult Care
  • Abstract Number: 0717
    Predictors of Clinical Remission in Children with Extended Oligoarticular Arthritis, Enthesitis-related Arthritis, or Psoriatic Arthritis Treated with Etanercept in the CLIPPER Studies
  • Abstract Number: 1163
    Predictors of Colchicine Response in Patients with Undefined Systemic Autoinflammatory Diseases
  • Abstract Number: 0200
    Predictors of Durable Clinical Response to Tofacitinib 11 Mg Once Daily with or Without Methotrexate in Patients with Rheumatoid Arthritis: Post Hoc Analysis of Data from a Phase 3b/4 Methotrexate Withdrawal Study
  • Abstract Number: 1935
    Predictors of Early Mortality for Giant Cell Arteritis at the Time of Diagnosis
  • Abstract Number: 1288
    Predictors of Frailty Identified by the Short Physical Performance Battery and Associations with Patient-reported Outcomes
  • Abstract Number: 0261
    Predictors of Future Repeat Renal Biopsies in Patients with Lupus Nephritis and Influence of Repeat Biopsy in Flare Management: A Retrospective Study
  • Abstract Number: 2028
    Predictors of Maintaining Inactive Disease After Etanercept Withdrawal, and Regaining Inactive Disease Status After Flare and Retreatment, in Adults with Non-radiographic Axial Spondyloarthritis: Results from RE-EMBARK
  • Abstract Number: 1347
    Predictors of Response in Patients with Non-Radiographic Axial Spondyloarthritis Receiving Certolizumab Pegol in the C-axSpAnd Study
  • Abstract Number: 1893
    Predictors of Response in Secukinumab-treated Patients with Ankylosing Spondylitis: Logistic Regression and Machine Learning Analyses
  • Abstract Number: 1475
    Predictors of Thirty-Day Hospital Readmissions in Systemic Lupus Erythematosus in the US: A Nationwide Study
  • Abstract Number: 1716
    Predictors of Unacceptable Pain and Unacceptable Pain with Low Inflammation in Early Rheumatoid Arthritis
  • Abstract Number: 1944
    Predictors of Visual Loss and Cerebrovascular Accidents in Giant Cell Arteritis
  • Abstract Number: 1781
    Pregnancy After Bariatric Surgery in Women with Rheumatic Diseases and Association with Adverse Birth Outcomes
  • Abstract Number: 1323
    Pregnancy in Axial Spondyloarthropathy: A Systematic Review & Meta-Analysis
  • Abstract Number: 1498
    Pregnancy Outcomes in Patients with Axial Spondyloarthritis – a First Analysis of a European Collaboration of Pregnancy Registries
  • Abstract Number: 1446
    Pregnancy Outcomes in Patients with Interstitial Lung Disease
  • Abstract Number: 1639
    Preliminary Baseline Subject Demographics and Disease Characteristics in a Phase 3 Clinical Trial of the Safety and Efficacy of Lenabasum in Dermatomyositis (DETERMINE)
  • Abstract Number: 2019
    Preliminary Definition of a Positive MRI for Active Lesions in the Sacroiliac Joints Typical of Axial Spondyloarthritis
  • Abstract Number: 2020
    Preliminary Definition of a Positive MRI for Structural Lesions in the Sacroiliac Joints in Axial Spondyloarthritis
  • Abstract Number: 0759
    Presence of Ultrasound Imaging Biomarkers Are Good Predictors of Arthritis Development in a Population at Risk for Rheumatoid Arthritis
  • Abstract Number: 0860
    PREVAIL 1: A Multiple Ascending Dose Study in Normal Healthy Volunteers of PRV-3279, a Novel Bispecific DART Molecule Targeting CD32B and CD79B on B Cells, with Potential for Treatment of SLE
  • Abstract Number: 1322
    Prevalence and Associated Factors of Sleep Disorders in Patients with Axial Spondyloarthritis. Results from the European Map of Axial Spondyloarthritis (EMAS)
  • Abstract Number: 0401
    Prevalence and Characteristics of Systemic Sclerosis Patients Fulfilling the 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus
  • Abstract Number: 0645
    Prevalence and Clinical Features of COVID-19 in a Large Cohort of 199 Patients with Sarcoidosis
  • Abstract Number: 2015
    Prevalence and Distribution of Peripheral Musculoskeletal Manifestations in Axial Spondyloarthritis, Peripheral Spondyloarthritis and Psoriatic Arthritis: Results of the International, Cross-sectional ASAS-PerSpA Study
  • Abstract Number: 1978
    Prevalence and Factors Associated with Patient-Physician Discordance Among RA Patients Initiating Advanced Therapy
  • Abstract Number: 0166
    Prevalence and Impact of Unacceptable Symptom State Among Patients with Psoriatic Arthritis: Results from the National Psoriasis Foundation’s 2019 Annual Survey
  • Abstract Number: 1758
    Prevalence and Incidence of Infection and Venous Thromboembolism in Rheumatoid Arthritis Patients Newly Initiating Various DMARD Classes: Real-World Analysis of 2012–2016 US Medicare Data
  • Abstract Number: 0225
    Prevalence and Probability Assessment of Adverse Drug Reactions in Rheumatoid Arthritis Patients Receiving Intravenous Originator Biologics in Saudi Arabia: A Longitudinal Five Years Follow-up Study
  • Abstract Number: 0264
    Prevalence and Risk Factors Associated with Isolated Neutropenia in Outpatients with Systemic Lupus Erythematosus
  • Abstract Number: 0392
    Prevalence and Survival of Systemic Sclerosis (SSc) and Associated Interstitial Lung Disease (ILD) in Ontario, Canada over 10 Years
  • Abstract Number: 1719
    Prevalence and Trajectory of Erosions, Synovitis, and Bone Marrow Edema in Feet of Patients with Early Rheumatoid Arthritis
  • Abstract Number: 1025
    Prevalence Estimates for Systemic Lupus Erythematosus over Four Decades
  • Abstract Number: 0394
    Prevalence of a Diagnosis of Osteopenia/Osteoporosis Amongst Patients with Systemic Sclerosis and Identification of Associated Clinical Factors
  • Abstract Number: 1426
    Prevalence of ANCA-associated Vasculitis and Spatial Association with Quarries in a French Northeast Region: A Capture-recapture and Geospatial Analysis
  • Abstract Number: 1066
    Prevalence of Cervical Dysplasia in Women with Antisynthetase Syndrome
  • Abstract Number: 1313
    Prevalence of Extra-Articular Manifestations in Early Ankylosing Spondylitis versus Non-Radiographic Axial Spondyloarthritis: A Systematic Literature Review and Meta-Analysis of 1504 Patients
  • Abstract Number: 1134
    Prevalence of Frailty and Associated Factors in a National Observational Cohort of Rheumatic Diseases
  • Abstract Number: 0009
    Prevalence of Hydroxychloroquine and Chloroquine Side Effects in Rheumatology Patients: A Retrospective Survey of 115 Cases
  • Abstract Number: 0185
    Prevalence of Migraine and Neuropathic Pain in Rheumatic Disease
  • Abstract Number: 1287
    Prevalence of Morbidity Prior to Diagnosis of Incident Systemic Lupus Erythematosus in the Danish Population
  • Abstract Number: 0132
    Prevalence of Osteoporosis and Fragitlity Fractures Is Not Different Between ACPA Positive Patients Compared to ACPA Negative Patients in a Real World Setting, Despite Longer Disease Duration and Glucocorticoid-Treatment
  • Abstract Number: 1199
    Prevalence of Subclinical Interstitial Lung Disease After a Mean Rheumatoid Arthritis Duration of 13 Years: Results from the French ESPOIR Cohort
  • Abstract Number: 0081
    Prevalence of Systemic Autoimmune Diseases in Polycystic Ovary Syndrome
  • Abstract Number: 0418
    Prevalence of Thyroid Disease Among Patients with Vasculitis
  • Abstract Number: 1543
    Prevalence of Ultrasound Findings Suggestive of Inflammatory Arthritis in Children with Skin Psoriasis (ChildEchoPso)
  • Abstract Number: 1309
    Prevalence of Undiagnosed Axial Spondyloarthritis Among Patients with Inflammatory Bowel Disease: A Secondary Care Cross-Sectional Study
  • Abstract Number: 0489
    Prevalence, Incidence, and Cause-Specific Mortality of Rheumatoid Arthritis-Associated Interstitial Lung Disease Among Older Patients with Rheumatoid Arthritis: A Nationwide Cohort Study
  • Abstract Number: 0451
    Prevalence, Therapy and Tumor Response in Patients with Rheumatic Immune-related Adverse Events Following Immune Checkpoint Inhibitor Therapy: A Single-Centre Analysis
  • Abstract Number: 1139
    Primary Non-adherence in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 1673
    Principles of Pediatric Lupus Nephritis in a Contemporary Multi-Center Cohort
  • Abstract Number: 0021
    Prioritizing Patient Safety While Maintaining Study Integrity During COVID-19: Lupus Intervention Fatigue Trial Modifications and Lessons Learned
  • Abstract Number: 1028
    Probabilistic Linkage of a Cohort of Individuals with Symptoms Suggestive of Early Spondyloarthritis and the French National Healthcare Database
  • Abstract Number: 0905
    Probability of Achieving Low Disease Activity or Remission with Apremilast Treatment Among DMARD-Naive Subjects with Active Psoriatic Arthritis
  • Abstract Number: 1635
    Profile of Topical Diclofenac Sodium Gel 1% (Voltaren®) Users in a United States Longitudinal Electronic Health Records Database
  • Abstract Number: 1435
    Prognostic Factors for Mononeuritis Multiplex Associated with ANCA-associated Vasculitis
  • Abstract Number: 1652
    Progression of Knee OA with Use of Intra-articular Corticosteroids (CS) vs Hyaluronic Acid (HA)
  • Abstract Number: 0901
    Proinflammatory Neutrophil Function Is Modulated During Secukinumab Therapy in Psoriatic Arthritis Without Compromising Host Defence
  • Abstract Number: 0018
    PROMIS-29 and Health Related Quality of Life in Rheumatology Outpatients During the COVID-19 Pandemic in New York City
  • Abstract Number: 0137
    PROMIS-29 Scores Are Significantly Higher in Patients with Rheumatoid Arthritis Who Meet Criteria for Co-morbid Fibromyalgia (FM) Than in Those with Rheumatoid Arthritis and No FM
  • Abstract Number: 1738
    Promote Treat-to-Target for RA via Empowering Patients: A Cohort Study from China by Smart System of Disease Management (SSDM)
  • Abstract Number: 1368
    Proportions of Patients Achieving a Minimal Disease Activity State upon Treatment with Tildrakizumab in a Psoriatic Arthritis Phase 2b Study
  • Abstract Number: 0832
    PROSARA – A Prospective, Multicenter, Noninterventional Study to Evaluate the Safety and Effectiveness of Sarilumab for the Treatment of Active Rheumatoid Arthritis in Regular Care in Germany
  • Abstract Number: 1047
    Prospective Analysis of a Cohort of Patients with Interstitial Lung Disease Associated with Connective Tissue Disease and Their Response to Immunosuppression with Mycophenolate Mofetil and Rituximab
  • Abstract Number: 1936
    Prospective Analysis of Flow Velocity of the Central Retinal Artery in Newly Diagnosed Patients with Giant Cell Arteritis with Visual Symptoms and Controls
  • Abstract Number: 0420
    Prospective Analysis of the Prevalence of Giant Cell Arteritis in Consecutive Newly Diagnosed Patients with Polymyalgia Rheumatica
  • Abstract Number: 0672
    Prospective Study of the Patterns of Joint Involvement for Sequential Gout Flares
  • Abstract Number: 1002
    Prostate Cancer Risk Is Not Increased in Rheumatoid Arthritis After Accounting for Retention in a Health Care System
  • Abstract Number: 0038
    Protein Biomarkers May Differentiate Responders and Non-Responders to Adalimumab, a Tumour Necrosis Factor Inhibitor, in Ankylosing Spondylitis Patients – The Bioefficacy SpA Study
  • Abstract Number: 1439
    Proteinase 3-Reactive B Cell Pool Restructuring After Rituximab and Risk of Relapse in Severe PR3-ANCA-Associated Vasculitis
  • Abstract Number: 0429
    Prothrombotic Antiphospholipid Antibodies in COVID-19
  • Abstract Number: 0535
    Provider Opinion and Support for Shared Decision-making in Gout Treatment: A Quality Improvement National Survey of Veterans Affairs Rheumatologists
  • Abstract Number: 1523
    Pulmonary Cytokine, Chemokine and Growth Factor Profiles of Distinct Radiographic Patterns of Interstitial Lung Disease in Systemic Sclerosis
  • Abstract Number: 0279
    Pulmonary Involvement in a Single Center Cohort of Patients with Systemic Lupus Erythematosus
Jump to:  View All • a b c d e f g h i j k l m n o [p] q r s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.